MouseScan™ Murine Proteome PhIP-Seq

Entire Murine Proteome in a Single Tube Assay

MouseScan™, an application of Phage ImmunoPrecipitation Sequencing (PhIP-Seq), is composed of the entire mouse proteome.

REQUEST INFO
  • PROMO: For a limited time, we're offering first-time customers 50% off PhIP-Seq analysis of 10 samples.
  • LEARN MORE

MouseScan™ PhIP-Seq Overview

Phage ImmunoPrecipitation Sequencing (PhIP-Seq) is a powerful method of multiplexed analysis that combines DNA high-throughput sequencing with next-generation proteomics

PhIP-Seq allows researchers to determine what antibodies were created by a mouse's unique history of immune exposures. PhIP-Seq is the highest-coverage antigen-specific assay yet developed, able to detect antibodies versus virtually any antigen via overlapping long peptides. MouseScan enables simultaneous epitope-level autoantibody profiling versus an entire GRCm38.p5 mouse proteome (50,135 proteins and isoforms) via phage immunoprecipitation sequencing.

MouseScan Figure

MouseScan PhIP-Seq is composed of the entire normal mouse proteome (GRCm38.p5). The library contains all proteins expressed as overlapping 62-mer peptide tiles on the surface of bacteriophages. For an assay, an aliquot from this library is reacted with diluted mouse serum or other antibody-containing fluid. Bound antibodies are immunoprecipitated with protein A/G beads, the precipitate amplified by PCR, and the sequences quantified by a next-generation sequencing and analysis pipeline that compares patient-sample IP read counts to negative controls with no antibody input (mock IPs) in the context of overall clonal frequency of individual peptides in the parent library. Output data are then created at both the peptide level.

MouseScan Technology Overview

Data and technology validated by scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and technology validated by scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and technology validated by scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)